Metastatic disease from uveal melanoma: treatment options and future prospects
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metastatic disease from uveal melanoma: treatment options and future prospects
Authors
Keywords
-
Journal
BRITISH JOURNAL OF OPHTHALMOLOGY
Volume 101, Issue 1, Pages 38-44
Publisher
BMJ
Online
2016-08-30
DOI
10.1136/bjophthalmol-2016-309034
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase III random assignment trial comparing percutaneous hepatic perfusion with melphalan (PHP-mel) to standard of care for patients with hepatic metastases from metastatic ocular or cutaneous melanoma.
- (2017) J. F. Pingpank et al. JOURNAL OF CLINICAL ONCOLOGY
- Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT)
- (2015) Richard D. Carvajal et al. BMC CANCER
- Abstract 4262: PRAME as a biomarker for a new molecular subclass of uveal melanoma
- (2015) Matthew G. Field et al. CANCER RESEARCH
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
- (2015) Jeffrey S Weber et al. LANCET ONCOLOGY
- The Mayo Clinic experience with the use of kinase inhibitors, ipilimumab, bevacizumab, and local therapies in the treatment of metastatic uveal melanoma
- (2015) Justin C. Moser et al. MELANOMA RESEARCH
- A phase 2 study of tremelimumab in patients with advanced uveal melanoma
- (2015) Anthony M. Joshua et al. MELANOMA RESEARCH
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Posterior Uveal Melanoma: Past, Present, and Future
- (2015) Jerry A. Shields et al. OPHTHALMOLOGY
- Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
- (2015) Lisa Zimmer et al. PLoS One
- Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial
- (2014) S. Leyvraz et al. ANNALS OF ONCOLOGY
- Dabrafenib Therapy for Advanced Melanoma
- (2014) Van Anh Trinh et al. ANNALS OF PHARMACOTHERAPY
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma
- (2014) Richard D. Carvajal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
- (2014) Caroline Robert et al. LANCET
- Clinical application of adoptive T cell therapy in solid tumors
- (2014) Zong-You Chen MEDICAL SCIENCE MONITOR
- Single Nucleotide Polymorphism Array Analysis of Uveal Melanomas Reveals That Amplification of CNKSR3 Is Correlated With Improved Patient Survival
- (2013) Sarah L. Lake et al. AMERICAN JOURNAL OF PATHOLOGY
- Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma
- (2013) M. Maio et al. ANNALS OF ONCOLOGY
- Isolated Hepatic Perfusion for Ocular Melanoma Metastasis: Registry Data Suggests a Survival Benefit
- (2013) R. Olofsson et al. ANNALS OF SURGICAL ONCOLOGY
- Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma
- (2013) Nathalie Cassoux et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options
- (2013) Sanjiv S. Agarwala et al. CANCER
- Clinical activity of ipilimumab for metastatic uveal melanoma
- (2013) Jason J. Luke et al. CANCER
- KRASMutation: Should We Test for It, and Does It Matter?
- (2013) Patrick J. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of metastatic uveal melanoma with intravenous fotemustine
- (2013) Francesco Spagnolo et al. MELANOMA RESEARCH
- Inhibition of Mutant GNAQ Signaling in Uveal Melanoma Induces AMPK-Dependent Autophagic Cell Death
- (2013) G. Ambrosini et al. MOLECULAR CANCER THERAPEUTICS
- Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3
- (2013) Marcel Martin et al. NATURE GENETICS
- Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
- (2013) J William Harbour et al. NATURE GENETICS
- Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations
- (2013) X Chen et al. ONCOGENE
- SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
- (2013) S. J. Furney et al. Cancer Discovery
- Association of Ocular and Oculodermal Melanocytosis With the Rate of Uveal Melanoma Metastasis
- (2013) Carol L. Shields et al. JAMA Ophthalmology
- Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study
- (2012) S Thomas et al. BRITISH JOURNAL OF CANCER
- MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients
- (2012) Ernie Marshall et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Radioembolization as Locoregional Therapy of Hepatic Metastases in Uveal Melanoma Patients
- (2012) A. Klingenstein et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance
- (2012) G. Ambrosini et al. CLINICAL CANCER RESEARCH
- Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture
- (2012) B Damato EYE
- Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET ONCOLOGY
- Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
- (2012) Jeffrey R Infante et al. LANCET ONCOLOGY
- Protein Kinase C Inhibitor AEB071 Targets Ocular Melanoma Harboring GNAQ Mutations via Effects on the PKC/Erk1/2 and PKC/NF- B Pathways
- (2012) X. Wu et al. MOLECULAR CANCER THERAPEUTICS
- Detection and Time to Treatment of Uveal Melanoma in the United Kingdom: An Evaluation of 2384 Patients
- (2012) Erika M. Damato et al. OPHTHALMOLOGY
- Collaborative Ocular Oncology Group Report Number 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma
- (2012) Michael D. Onken et al. OPHTHALMOLOGY
- The genetics of uveal melanoma: an emerging framework for targeted therapy
- (2012) J. William Harbour Pigment Cell & Melanoma Research
- Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma
- (2011) S. Landreville et al. CLINICAL CANCER RESEARCH
- Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers
- (2011) M. H. Abdel-Rahman et al. JOURNAL OF MEDICAL GENETICS
- Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
- (2011) F. M. Yakes et al. MOLECULAR CANCER THERAPEUTICS
- Uveal Melanoma: Trends in Incidence, Treatment, and Survival
- (2011) Arun D. Singh et al. OPHTHALMOLOGY
- A Melanoma Molecular Disease Model
- (2011) Smruti J. Vidwans et al. PLoS One
- Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice
- (2010) Cathrine L. Denton et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Genotypic Profiling of 452 Choroidal Melanomas with Multiplex Ligation-Dependent Probe Amplification
- (2010) B. Damato et al. CLINICAL CANCER RESEARCH
- The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer
- (2010) U. Banerji et al. CLINICAL CANCER RESEARCH
- Mutations inGNA11in Uveal Melanoma
- (2010) Catherine D. Van Raamsdonk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
- (2010) J. W. Harbour et al. SCIENCE
- Locoregional Management of Hepatic Metastasis From Primary Uveal Melanoma
- (2010) Takami Sato SEMINARS IN ONCOLOGY
- Effectiveness of Treatments for Metastatic Uveal Melanoma
- (2009) James J. Augsburger et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Liver Resection for Metastatic Melanoma with Postoperative Tumor-Infiltrating Lymphocyte Therapy
- (2009) R. Taylor Ripley et al. ANNALS OF SURGICAL ONCOLOGY
- Metastasis of Uveal Melanoma Millimeter-by-Millimeter in 8033 Consecutive Eyes
- (2009) Carol L. Shields ARCHIVES OF OPHTHALMOLOGY
- Targeted therapy for uveal melanoma
- (2008) Pierre L. Triozzi et al. CANCER TREATMENT REVIEWS
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
- (2008) Catherine D. Van Raamsdonk et al. NATURE
- Hepatic Arterial Chemoembolization for Management of Metastatic Melanoma
- (2007) Karun V. Sharma et al. AMERICAN JOURNAL OF ROENTGENOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now